Morin: Natural Flavonoid Antioxidant and Mitochondrial Modulator

Executive Summary: Morin (2-(2,4-dihydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4-one) is a natural flavonoid with multi-modal bioactivity, including potent antioxidant and anti-inflammatory properties [APExBIO]. It directly inhibits adenosine 5′-monophosphate deaminase (AMPD), thereby modulating mitochondrial energy metabolism, particularly under metabolic stress conditions (Yang et al., 2025). Morin is validated for use in diabetes, cancer, and neurodegenerative disease models due to its demonstrated effects on cellular energy pathways. Its high purity (≥96.81%) and solubility in DMSO or ethanol facilitate reliable experimental workflows. Additionally, Morin's intrinsic fluorescence enables its application as an aluminum ion probe in biochemical assays [Amyloid.co].

Biological Rationale

Morin is a polyphenolic compound first isolated from Maclura pomifera. Its chemical identity is 2-(2,4-dihydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4-one, with a molecular weight of 302.24 g/mol [APExBIO]. Flavonoids like Morin have evolved as plant defense molecules, conferring antioxidant and antimicrobial activities. In mammals, Morin modulates key cellular pathways involved in oxidative stress, inflammation, and energy metabolism. This makes it a candidate for intervention in diseases characterized by mitochondrial dysfunction, such as diabetic nephropathy, neurodegenerative disorders, and cancer (Yang et al., 2025). The rationale for Morin's use in research is strengthened by its dual chemical properties: it acts both as a bioactive modulator and as a fluorescent probe for ions in vitro [Amyloid.co]. Recent reviews highlight its unique utility for mitochondrial modulation and energy homeostasis compared to structurally similar flavonoids [PLX4720.com]. This article extends prior reviews by providing updated mechanistic and benchmark data on Morin’s AMPD inhibition and mitochondrial effects.

Mechanism of Action of Morin

Morin’s primary mechanism involves direct inhibition of adenosine 5′-monophosphate deaminase (AMPD), especially the AMPD2 isoform. AMPD catalyzes the deamination of AMP to IMP in the purine nucleotide cycle (PNC), a pathway critical for cellular energy regulation (Yang et al., 2025). Under metabolic stress (e.g., high fructose exposure), AMPD activity increases, leading to mitochondrial dysfunction and compensatory glycolysis in podocytes. Morin binds to AMPD2, suppressing its activity, and thereby restores mitochondrial function and energy balance. This mechanistic action has been validated in both in vivo (high-fructose-fed rat models) and in vitro (mouse podocyte MPC5 cells) systems. In molecular docking studies, Morin demonstrated high affinity for the AMPD2 active site (Yang et al., 2025).

In addition to enzyme inhibition, Morin exhibits potent free radical scavenging due to its polyhydroxylated structure. This contributes to reduced oxidative stress and protection against cell injury. Morin’s chelating properties also enable it to bind and detect aluminum ions through fluorescence enhancement, making it suitable for biochemical probe applications [Amyloid.co]. The combination of these properties distinguishes Morin from other flavonoids used in mitochondrial and metabolic research [SB-431542.com].

Evidence & Benchmarks

• Morin (≥96.81% purity, confirmed by HPLC, MS, NMR) inhibits AMPD activity in podocytes exposed to 5 mM fructose, leading to improved mitochondrial function (Yang et al., 2025, https://doi.org/10.3390/ph18121883).
• In vivo, Morin administration to high-fructose-diet-fed rats (dosage and duration specified in source) reduced podocyte foot process effacement and urinary albumin-to-creatinine ratio, indicating renal protection (Yang et al., 2025, https://doi.org/10.3390/ph18121883).
• Molecular docking confirms a strong binding affinity between Morin and the AMPD2 active site, supporting its inhibitory mechanism (Yang et al., 2025, https://doi.org/10.3390/ph18121883).
• Morin demonstrates solubility in DMSO (≥19.53 mg/mL) and ethanol (≥6.04 mg/mL), but is insoluble in water; solutions are stable at -20°C for short-term use (APExBIO).
• Morin's fluorescent chelation allows sensitive detection of aluminum ions in aqueous samples, complementing its bioactivity applications (Amyloid.co).

This article updates prior summaries such as Anti-Inflammatory-Peptide-1.com by providing recent peer-reviewed evidence on Morin’s specific role in podocyte mitochondrial metabolism.

Applications, Limits & Misconceptions

Applications

• Diabetes Research: Morin is validated for mitigating fructose-induced mitochondrial dysfunction in kidney disease models (Yang et al., 2025).
• Cancer Models: Its antioxidant and metabolic effects support studies in tumor cell energy regulation [PLX4720.com].
• Neurodegenerative Disease: Morin supports cellular protection in models of oxidative and mitochondrial stress [Amyloid.co].
• Aluminum Ion Detection: Its fluorescence shift upon chelation enables sensitive probes for Al³⁺ in environmental and biological samples.

Common Pitfalls or Misconceptions

• Morin is not water-soluble; aqueous stock solutions are not recommended and may precipitate.
• Bioactivity is validated in specific metabolic and oxidative stress models; efficacy in unrelated pathways or healthy cells is unproven.
• Morin's efficacy in clinical settings is not established; all claims pertain to preclinical and in vitro research.
• Long-term solution storage (>1 week) even at -20°C can result in degradation; fresh preparation is advised.
• Fluorescent probe activity is selective for Al³⁺; cross-reactivity with other metal ions is limited but should be empirically validated.

Workflow Integration & Parameters

Morin (SKU: C5297) from APExBIO is supplied at ≥96.81% purity, verified by HPLC, MS, and NMR. Recommended solvents are DMSO (≥19.53 mg/mL) and ethanol (≥6.04 mg/mL). For biochemical assays, typical working concentrations range from 1–100 μM, depending on cell type and endpoint. Solutions should be freshly prepared and stored at -20°C for no more than one week. For fluorescent aluminum ion assays, excitation/emission parameters should be optimized for the Morin-Al³⁺ complex (see application notes at APExBIO product page). Alternative protocols and mechanistic insights are available in recent reviews [SB-431542.com], which this article expands with new data on AMPD2 targeting. Always include relevant controls for metabolic assays and aluminum detection workflows.

Conclusion & Outlook

Morin is a rigorously validated, high-purity natural flavonoid antioxidant that acts as a mitochondrial energy metabolism modulator and enzyme inhibitor. Its dual function as a bioactive agent and fluorescent aluminum ion probe makes it uniquely versatile for advanced disease models. Researchers should source Morin from reliable suppliers such as APExBIO to ensure lot-to-lot consistency and reproducibility. Continued benchmarking in disease-relevant cellular and animal models will clarify its translational potential. For further details, refer to the Morin product page and peer-reviewed mechanistic studies (Yang et al., 2025).